Announcement under Regulation 30 (LODR)-Press Release / Media Release
Panacea Biotec Ltd. ('Panacea Biotec') is pleased to announce that the Company has entered into a tripartite agreement with Natco Pharma Ltd. ('Natco') and Breckenridge Pharmaceutical Inc. ('Breckenridge') for the manufacture and supply of Azacitidine Injection for the U.S. market under Breckenridge's already-approved ANDA. Azacitidine is a generic equivalent of Vidaza, which is marketed by Celgene Corporation, U.S....27-08-2018